Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Performer
3535.5000 3.90 (0.11%)
NSE Sep 16, 2025 15:31 PM
Volume: 109.9K
 

3535.50
0.11%
Dolat Capital
While India continue to lead growth (pre-buying in March aided growth, in-line), exports were a drag. Gross margin at 72.4% was a function of strong growth in India, leading to impressive EBITDA margin of 28.2% (our estimate: 25.4%). Though company remains confident of outperforming IPM growth, we remain wary of the exports (US 2 key facilities under WL and OAI, Brazil adverse currency and batch traceability regulations in Germany) given the weaker outlook....
Number of FII/FPI investors increased from 913 to 923 in Jun 2025 qtr.
More from Torrent Pharmaceuticals Ltd.
Recommended